888-882-8602

Give us 30 Days.
We'll introduce you to
a smarter way
to help manage^∆ Diabetes.

Ready to find a way to help outsmart your diabetes?
The Guardian^™ Connect CGM¹ evaluation program allows you to try out the Guardian^™ Connect CGM¹ system at no charge for 30 days.

Participate in our
No Charge 30-Day Evaluation Program.

Call Today 888-882-8602.

Are you an existing Medtronic customer?

Yes No

Do you have insurance coverage through Medicare, Medicaid, Kaiser or CareCentrix?

Yes No

Select one or more of the below:

I have read and understand the terms of this marketing authorization. I hereby knowingly and voluntarily authorize Medtronic to use such information for the purposes described in the authorization.

AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION

You authorize Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes or its subsidiaries, contractors or representatives to use your personal information, including but not limited to your contact information and health information, for marketing purposes and to share that information with Medtronic representatives and contractors. Information you may receive includes, but is not limited to: (a) Medtronic Diabetes products, therapies or services; (b) marketing and promotional offers; (c) inquiries about your experience with Medtronic Diabetes products, therapies and services; and/or (d) suggestions for how Medtronic Diabetes can enhance its customer support.

This authorization will expire three (3) years from the later of the date you submit this authorization online; or (ii) the last date products or services were received from Medtronic, but may expire sooner if you revoke it by following the instructions below.

You have the right to revoke this authorization at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating my communication preferences at www.diabetes.shop/myhome. A revocation will not affect actions Medtronic Diabetes has already taken based on this authorization. Information disclosed pursuant to this authorization may be re-disclosed by the recipient of the information and may no longer be protected by the federal privacy standards.

You have the right to refuse to sign this authorization. Refusal to sign will not affect your treatment or health insurance eligibility or benefits.

Questions? Contact our Customer Service Center at 800-646-4633, or by email at takecontrol@medtronic.com.

I have read and understand the terms of this phone communications. I consent to receive phone calls and/or artificial or prerecorded voice messages at the phone number(s) provided above sent from or on behalf of Medtronic Diabetes using automated technology.

CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS

You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

I have read and understand the terms of this text communications. I consent to receive text communications at the mobile phone number provided above using automated technology sent from or on behalf of Medtronic Diabetes (message frequency may vary).

CONSENT FOR RECEIPT OF TEXT COMMUNICATIONS

You consent to receiving text messages at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) texting "STOP" in return to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

IS CONTINUOUS GLUCOSE MONITORING (CGM) FOR ME?

Medtronic offers CGM systems for people living with type 1 or type 2 diabetes who want better
glucose control. CGM may be beneficial for people who:

Have frequent low glucose levels
Are unaware of their low blood sugars
Have wide changes in blood sugar levels
Want to keep their loved ones informed of urgent issues
Need help figuring out how lifestyle choices impact glucose levels²

Benefits of CGM.

A blood glucose meter only provides a brief “snapshot” of your glucose level at a single moment in time. A CGM system gives you a greater view of your glucose trends. CGM can provide valuable information² at crucial points during the day, including before and during exercise, prior to driving, before test-taking, and in the middle of the night.

The only CGM with 60 minute in advance prediction of highs and lows³

Text notification to five loved ones with alerts of your choosing

The direction your glucose levels are going

Customizable notifications of upcoming highs and lows throughout the day and night

Visibility of time spent high, low, and within a healthy glucose range of 70 – 180 mg/dL

Insights into how food, insulin, time of day, and other lifestyle decisions impact glucose levels²

DIABETES MANAGEMENT

MADE SMARTER.

GUARDIAN^™ CONNECT APP

Check your glucose levels and trends anytime, right on your phone and set alerts anywhere from 10 to 60 minutes before a high or low happens, getting notified exactly when you want.

How it works

GUARDIAN^™ SENSOR 3 AND GUARDIAN^™ CONNECT TRANSMITTER

The system includes a small sensor worn up to seven days and a slim, discreet Bluetooth^® transmitter. They work together to send precise glucose readings automatically to your mobile phone every five minutes.

Sugar.IQ^™ app

See the fuller picture of your diabetes, you can more easily and confidently make adjustments to keep your levels² in check.

How it works

GUARDIAN^TM CONNECT CGM.

A SMARTER CHOICE.

Feature	Why It's Important	Guardian^™ Connect System	Other Continuous Glucose Monitoring	Flash Glucose Monitoring
Performance
Predictive alerts	To help you take action to avoid that unpleasant feeling that comes with being high or low.	up to 60 minutes in advance³	up to 20 minutes in advance³	⁴

Convenience
Caregiver Data Share	The people that are important to supporting your diabetes management receive alerts when it matters most

Convenience
Sugar.IQ^™ Diabetes Assistant	The Sugar.IQ app uses IBM Watson^™ to provide intelligent insights that help you make more informed decisions²

1. Continuous Glucose Monitor
2. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system.
3. Dexcom IFU, Guardian^™ Connect user guide
4. Projected alerts available only with user invention of system scan per Freestyle Libre IFU.
5. Per system description, a dedicated monitor must be purchased

∆The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.

*Individual shown is a compensated Medtronic Diabetes Ambassador. All thoughts and opinions expressed are his/her own.

By submitting this form, you are granting Medtronic MiniMed, Inc. ("Medtronic") permission to add your contact information to its database for sending you additional information and communications related to Medtronic products and therapies. You may revoke this permission at any time by e-mailing takecontrol@medtronic.com or by sending a request in writing to: Medtronic MiniMed, Inc. c/o Customer Support, 18000 Devonshire Street, Northridge, CA 91325-1219

Important Safety Information: Guardian™ Connect CGM System
The Guardian Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides andhttp://www.medtronicdiabetes.com/importantsafetyinformation.

With Watson is a trademark of International Business Machines Corporation, registered in many jurisdictions worldwide.

930M19653-012 26MAR2019 © Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.

Give us 30 Days.We'll introduce you to a smarter wayto help manage∆ Diabetes.

Participate in ourNo Charge 30-Day Evaluation Program.